SCHEMBL9059565

SCHEMBL9059565

Cc1cccc(N2CCSCC2)c1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGMN Q99538 2/20 0.46
ADRB1 P08588 2/20 0.42
CD44 P16070 1/20 0.41
ALDH1A1 P00352 4/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
ADRA2C P18825 1/20 0.37
HTR7 P34969 1/20 0.37
ACHE P22303 1/20 0.36
NOTUM Q6P988 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
GAA P10253 3/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
KEAP1 Q14145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9059115 0.81 KEAP1 (0.55) ADRB1CD44ALDH1A1NPSR1MAPT
SCHEMBL3436360 0.81 ADRB1 (0.60) LGMNADRB1ALDH1A1TSHRHTR7
SCHEMBL3555024 0.80 ADRA2C (0.59) ALDH1A1MAPTL3MBTL1MAPK1ADRA2C
SCHEMBL9059418 0.79 PRKDC (0.49) LGMNADRB1ALDH1A1NPSR1MAPT
SCHEMBL31321222 0.76 ALDH1A1 (0.41) ADRB1CD44ALDH1A1NPSR1MAPT
SCHEMBL27195995 0.76 ALDH1A1 (0.41) ADRB1CD44ALDH1A1NPSR1MAPT
SCHEMBL9060134 0.73 ALDH1A1 (0.55) ADRB1ALDH1A1MAPTTSHRMAPK1
SCHEMBL9424080 0.73 KEAP1 (0.64) LGMNALDH1A1MAPTL3MBTL1MAPK1
SCHEMBL4764212 0.71 ADRB1 (0.42) LGMNADRB1ALDH1A1NPSR1MAPT
SCHEMBL29039627 0.71 MAPT (0.69) LGMNALDH1A1MAPTMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed